Kiromic Biopharma (KRBP)
OTHER OTC:KRBP
US Market
Holding KRBP?
Track your performance easily

Kiromic Biopharma (KRBP) Financial Statements

19 Followers

Kiromic Biopharma Financial Overview

Kiromic Biopharma's market cap is currently ―. The company's EPS TTM is $-21.614; its P/E ratio is -0.04; Kiromic Biopharma is scheduled to report earnings on May 10, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -6.50M$ -5.87M$ -5.08M$ -6.43M$ -4.86M
EBITDA$ -5.79M$ -5.00M$ -4.52M$ -5.24M$ -4.22M
Net Income Common Stockholders$ -7.43M$ -6.83M$ -6.15M$ -6.76M$ -5.30M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.92M$ 4.05M$ 3.68M$ 2.70M$ 2.05M
Total Assets$ 10.24M$ 12.46M$ 12.63M$ 13.64M$ 13.11M
Total Debt$ 14.71M$ 13.37M$ 13.58M$ 10.10M$ 11.97M
Net Debt$ 11.79M$ 9.32M$ 9.90M$ 7.40M$ 9.91M
Total Liabilities$ 19.53M$ 17.63M$ 19.84M$ 19.93M$ 21.25M
Stockholders Equity$ -9.29M$ -5.17M$ -7.21M$ -6.29M$ -8.14M
Cash Flow-
Free Cash Flow$ -2.15M$ -8.28M$ -5.72M$ -6.46M$ -4.13M
Operating Cash Flow$ -1.93M$ -8.18M$ -5.70M$ -6.46M$ -4.13M
Investing Cash Flow$ -219.00K$ -98.00K$ -21.00K--
Financing Cash Flow$ 1.03M$ 8.78M$ 6.19M$ 7.11M$ 5.54M
Currency in USD

Kiromic Biopharma Earnings and Revenue History

Kiromic Biopharma Debt to Assets

Kiromic Biopharma Cash Flow

Kiromic Biopharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis